Company Overview of Atlantic Healthcare plc
Atlantic Healthcare plc focuses on the development and commercialization of specialty pharmaceutical products for patients under the management of physicians in the hospital and specialist care sector. Its product pipeline includes Alicaforsen Enema, an anti-inflammatory intercellular adhesion molecule inhibitor that acts by inhibiting a key protein in the inflammation process. The company offers its product for the treatment of pouchitis and ulcerative colitis. Atlantic Healthcare plc was founded in 2006 and is based in Saffron Walden, United Kingdom.
12 Rose & Crown Walk
Saffron Walden, CB10 1JH
Founded in 2006
Key Executives for Atlantic Healthcare plc
Founder, Chief Executive Officer and Director
Director of International Operations
Chief Executive Officer of Atlantic Pharmaceuticals
Compensation as of Fiscal Year 2016.
Atlantic Healthcare plc Key Developments
Atlantic Healthcare plc Establishes U.S. Commercial and Business Development Operations and Facility; Announces Executive Appointments
May 26 16
Atlantic Healthcare plc announced it has established U.S. commercial and business development operations and a facility to focus on the expansion and commercialisation of the Atlantic Healthcare product portfolio and pipeline.
The key management appointments include Sireesh Appajosyula, VP Product Commercialisation; Jonathan Drutz, VP Corporate & Business Development; and Jordan Zwick, Director of Corporate & Business Development, who will operate out of Atlantic Healthcare's new office in Research Triangle Park, North Carolina. Sireesh Appajosyula, joins the company from Salix Pharmaceuticals, where he led the commercial strategy for the Inflammatory Bowel Disease (IBD) division of the company. Jonathan Drutz has been involved in numerous life science ventures as a business development executive, investor and consultant. Jordan Zwick is also a former member of the Salix team, and will work alongside Sireesh assisting with the U.S. launch activities for alicaforsen.
Atlantic Healthcare plc Appoints Lorin K Johnson as Chief Scientific Advisor
Mar 21 16
Atlantic Healthcare plc announced that in addition, Dr. Lorin K Johnson has been appointed to the Board of Directors and has joined Atlantic Healthcare as a member of the Leadership team as Chief Scientific Advisor, with immediate effect. Dr. Lorin K Johnson was previously the Scientific Founder of Salix Pharmaceuticals Inc. until its $15.8 billion acquisition in April 2015 by Valeant Pharmaceuticals International Inc. Prior to Salix, Dr. Johnson was Chief Scientist at California Biotechnology, Inc, and held academic positions at Stanford University School of Medicine and the University of California, San Francisco.
Atlantic Healthcare plc Presents at BIO-Europe Spring 2015, Mar-09-2015
Jan 29 15
Atlantic Healthcare plc Presents at BIO-Europe Spring 2015, Mar-09-2015 . Venue: Paris Expo - Porte de Versailles, Hall 5, Paris, France.
Similar Private Companies By Industry
Recent Private Companies Transactions
March 21, 2016
The information and data displayed in this profile are created and managed by Capital IQ, a Standard & Poor's company. Bloomberg.com does not create
or control the content. For inquiries, please contact Capital IQ directly by clicking
Most Searched Private Companies
Sponsored Financial Commentaries